|
1
|
Owens B: Kidney cancer. Nature.
537:S972016. View
Article : Google Scholar : PubMed/NCBI
|
|
2
|
Linehan WM, Schmidt LS, Crooks DR, Wei D,
Srinivasan R, Lang M and Ricketts CJ: The metabolic basis of kidney
cancer. Cancer Discov. 9:1006–1021. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ricketts CJ, De Cubas AA, Fan H, Smith CC,
Lang M, Reznik E, Bowlby R, Gibb EA, Akbani R, Beroukhim R, et al:
The cancer genome atlas comprehensive molecular characterization of
renal cell carcinoma. Cell Rep. 23:313–326.e315. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Turajlic S, Swanton C and Boshoff C:
Kidney cancer: The next decade. J Exp Med. 215:2477–2479. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Latif F, Tory K, Gnarra J, Yao M, Duh FM,
Orcutt ML, Stackhouse T, Kuzmin I, Modi W and Geil L:
Identification of the von Hippel-Lindau disease tumor suppressor
gene. Science. 260:1317–1320. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhang Y, Qin P, Tian L, Yan J and Zhou Y:
The role of mediator complex subunit 19 in human diseases. Exp Biol
Med (Maywood). 246:1681–1687. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Napoli C, Schiano C and Soricelli A:
Increasing evidence of pathogenic role of the mediator (MED)
complex in the development of cardiovascular diseases. Biochimie.
165:1–8. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chadick JZ and Asturias FJ: Structure of
eukaryotic Mediator complexes. Trends Biochem Sci. 30:264–271.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Singh N and Han M: sur-2, a novel gene,
functions late in the let-60 ras-mediated signaling pathway during
Caenorhabditis elegans vulval induction. Gene Dev. 9:2251–2265.
1995. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Grants JM, Goh GY and Taubert S: The
mediator complex of caenorhabditis elegans: Insights into the
developmental and physiological roles of a conserved
transcriptional coregulator. Nucl Acids Res. 43:2442–2453. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bourbon HM: Comparative genomics supports
a deep evolutionary origin for the large, four-module
transcriptional mediator complex. Nucleic Acids Res. 36:3993–4008.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Koschubs T, Seizl M, Larivière L, Kurth F,
Baumli S, Martin DE and Cramer P: Identification, structure, and
functional requirement of the Mediator submodule Med7N/31. EMBO J.
28:69–80. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhang X, Gao D, Fang K, Guo Z and Li L:
Med19 is targeted by miR-101-3p/miR-422a and promotes breast cancer
progression by regulating the EGFR/MEK/ERK signaling pathway.
Cancer Lett. 444:105–115. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Mehine M, Mäkinen N, Heinonen HR, Aaltonen
LA and Vahteristo P: Genomics of uterine leiomyomas: Insights from
high-throughput sequencing. Fertil Steril. 102:621–629. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhu LJ, Yan WX, Chen ZW, Chen Y, Chen D,
Zhang TH and Liao GQ: Disruption of mediator complex subunit 19
(Med19) inhibits cell growth and migration in tongue cancer. World
J Surg Oncol. 11:1162013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Joseph C, Macnamara O, Craze M, Russell R,
Provenzano E, Nolan CC, Diez-Rodriguez M, Sonbul SN, Aleskandarany
MA, Green AR, et al: Mediator complex (MED) 7: A biomarker
associated with good prognosis in invasive breast cancer,
especially ER+ luminal subtypes. Br J Cancer. 118:1142–1151. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chen ZL, Ma YY, Mou XZ and Zhang JG:
Upregulation of MED7 was associated with progression in
hepatocellular carcinoma. Cancer Biomark. 38:603–611. 2023.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Tan W, Peng S, Li Z, Zhang R, Xiao Y, Chen
X, Zhu J, Li B and Lv X: Identification of therapeutic targets and
prognostic biomarkers among genes from the mediator complex family
in the hepatocellular carcinoma tumour-immune microenvironment.
Comput Math Methods Med. 2022:20216132022. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sato S, Tomomori-Sato C, Tsai KL, Yu X,
Sardiu M, Saraf A, Washburn MP, Florens L, Asturias FJ, Conaway RC
and Conaway JW: Role for the MED21-MED7 hinge in assembly of the
mediator-RNA polymerase II holoenzyme. J Biol Chem.
291:26886–26898. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Steven A and Seliger B: The role of immune
escape and immune cell infiltration in breast cancer. Breast care
(Basel). 13:16–21. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2018. CA Cancer J Clin. 68:7–30. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Shuch B, Amin A, Armstrong AJ, Eble JN,
Ficarra V, Lopez-Beltran A, Martignoni G, Rini BI and Kutikov A:
Understanding pathologic variants of renal cell carcinoma:
Distilling therapeutic opportunities from biologic complexity. Eur
Urol. 67:85–97. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Goyal R, Gersbach E, Yang XJ and Rohan SM:
Differential diagnosis of renal tumors with clear cytoplasm:
Clinical relevance of renal tumor subclassification in the era of
targeted therapies and personalized medicine. Arch Pathol and Lab
Med. 137:467–480. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Choueiri TK and Motzer RJ: Systemic
therapy for metastatic renal-cell carcinoma. N Eng J Med.
376:354–366. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Quail DF and Joyce JA: Microenvironmental
regulation of tumor progression and metastasis. Nat Med.
19:1423–1437. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Coussens LM, Zitvogel L and Palucka AK:
Neutralizing tumor-promoting chronic inflammation: A magic bullet?
Science. 339:286–291. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Yu W, Zhang Z, Min D, Yang Q, Du X, Tang
L, Lin F, Sun Y, Zhao H, Zheng S, et al: Mediator of RNA polymerase
II transcription subunit 19 promotes osteosarcoma growth and
metastasis and associates with prognosis. Eur J Cancer.
50:1125–1136. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Huang S, Hölzel M, Knijnenburg T,
Schlicker A, Roepman P, McDermott U, Garnett M, Grernrum W, Sun C,
Prahallad A, et al: MED12 controls the response to multiple cancer
drugs through regulation of TGF-β receptor signaling. Cell.
151:937–950. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhou Y, Tan Y, Zhang Q, Duan Q and Chen J:
MED12 mutation as a potential predictive biomarker for immune
checkpoint inhibitors in pan-cancer. Eur J Med Re. 27:2252022.
View Article : Google Scholar
|
|
31
|
Zhang Y and Zhang Z: The history and
advances in cancer immunotherapy: Understanding the characteristics
of tumor-infiltrating immune cells and their therapeutic
implications. Cell Mol Immunol. 17:807–821. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Robinson PJ, Trnka MJ, Pellarin R,
Greenberg CH, Bushnell DA, Davis R, Burlingame AL, Sali A and
Kornberg RD: Molecular architecture of the yeast mediator complex.
eLife. 4:e087192015. View Article : Google Scholar : PubMed/NCBI
|
